Green Journals

Associations of PNPLA3 and TM6SF2 gene polymorphisms and systemic inflammation with MASLD severity in patients with heart failure

G. D. Fadieienko, Y. V. Nikiforova, I. E. Kushnir et al.

2026-9-30 Issue 3 Pages 5-10

DOI: 10.30978/mg-2026-3-5

The role of tauroursodeoxycholic acid in the comprehensive treatment of patients with metabolic-associated steatotic liver disease following cholecystectomy

Y. S. Sirchak, I. O. Vashchenko, I. I. Pushkash et al.

2026-9-30 Issue 3 Pages 62-72

DOI: 10.30978/mg-2026-3-62

Nutritional management of insulin resistance: from dietary patterns to personalized nutrition. Review

L. V. Zhuravlyova, O. M. Kryvonosova

2026-9-30 Issue 3 Pages 35-43

DOI: 10.30978/mg-2026-3-35

Prevalence and age- and sex-related characteristics of esophageal diseases among residents of the Lviv region

Y. B. Shvydkyi, S. V. Bychkova, Y. M. Savytskyi et al.

2026-9-30 Issue 3 Pages 18-23

DOI: 10.30978/mg-2026-3-18

Postcholecystectomy syndrome: a familiar stranger in the light of new evidence. Review

N. B. Gubergrits, N. V. Bieliaieva, T. L. Mozhyna

2026-9-30 Issue 3 Pages 24-34

DOI: 10.30978/mg-2026-3-24

Dynamics of clinical and laboratory markers and hepatogenic fatigue during the use of sublingual S-adenosyl-L-methionine («Agepta®») in patients with steatotic liver disease: an open-label prospective pilot study

E. H. Christian

2026-9-30 Issue 3 Pages 106-115

DOI: 10.30978/mg-2026-3-106

Current approaches to endoscopic diagnosis and monitoring of precancerous states of the stomach: review of current Guidelines MAPS III (2025)

V. M. Kulaets, P. R. Gerych, N. M. Kulaets

2026-9-30 Issue 3 Pages 49-61

DOI: 10.30978/mg-2026-3-49

Clinical and ultrasound markers of significant liver fibrosis in patients with metabolic dysfunction-associated steatotic liver disease and arterial hypertension

M. Y. Zak, N. Y. Ziuz, V. M. Bogomaz et al.

2026-9-30 Issue 3 Pages 11-17

DOI: 10.30978/mg-2026-3-11

Features of pharmacological and dietary management of functional dyspepsia in children. Review

V. I. Bobrova, Y. I. Proshchenko

2026-9-30 Issue 3 Pages 44-48

DOI: 10.30978/mg-2026-3-44

Efficacy and safety of an enterosorbent with a prebiotic component in the comprehensive management of small intestinal bacterial overgrowth in patients with systemic metabolic disorders

O. V. Barabanchyk, M. V. Saifullina

2026-9-30 Issue 3 Pages 89-96

DOI: 10.30978/mg-2026-3-89

Year	A+	A	B	C
2026			✓
2025			✓
2024			✓
2023
2021/2022
2020
2019
2018

Journal Report

Journal Information

Classification History

Recent Articles